2018/4 GaBI Journal Table of Contents


Editor’s Letter

Fourth and final issue of GaBI Journal’s seventh volume


Nomenclature for biosimilars; a continuing thorny issue

Original Research

Ongoing activities to influence the prescribing of proton pump inhibitors within the Scottish National Health Service: their effect and implications

Review Article

The need for distinct nomenclature for originator and biosimilar products

Meeting Report

First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report

Abstracted Scientific Content

US generic prescription drug markets 2004‒2016

Source URL: https://gabi-journal.net/2018-4-gabi-journal-table-of-contents.html

Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048